Advertisement

Author: Scott Smith

Slider Test

2024 Year in Review​:
Therapeutics, Diagnostics, and Deep Learning Models​
​ Alzheimer Disease Alzheimer Disease Monoclonal Antibody Kisunla Approved for Mild Alzheimer’s Disease Donanemab is comparable to the Alzheimer’s drug...

Read More

Year In Review – Endometrial Cancer

2024 Year in Review​:
Therapeutics, Diagnostics, and Deep Learning Models​
​ Endometrial Cancer Endometrial Cancer New FDA Approval Dostarlimab-gxly (Jemperli) On August 1, 2024, the FDA approved dostarlimab-gxly (Jemperli, GSK)...

Read More

For latest news and updates
Email-id is invalid